BioNTech ADRs drop after JPMorgan lowers outlook to “underweight”

U.S.-listed shares in BioNTech (NASDAQ:BNTX) dipped in early trading on Friday after analysts at JPMorgan downgraded their rating of the…

S&P, Nasdaq slip as caution prevails ahead of Powell comments

(Reuters) – The S&P 500 and Nasdaq fell on Friday as investors were on edge ahead of Federal Reserve Chair…

Sri Lanka bondholders raise concerns over debt deal transparency

(Reuters) – A group of creditors holding Sri Lanka’s international bonds said on Friday it welcomed the country’s debt restructuring…

Dollar retreats after PCE data points to cooling inflation; Powell set to speak

The U.S. dollar retreated in early European trade Friday, as a key inflation release added to expectations that U.S. interest…

Pfizer shares slip after drugmaker announces obesity pill setback

Shares in Pfizer (NYSE:PFE) slumped in early trading on Friday after the drugmaker said that the twice-daily form of its…

Earnings call: Duluth Holdings reports Q3 sales decline, eyes growth through new products and strategic investments

Duluth Holdings Inc (NASDAQ:DLTH) reported a 6.1% decrease in third-quarter net sales to $138 million, compared to the same period…

Alibaba dips on MS downgrade as PDD grabs spot of most valuable Chinese e-commerce firm

(Reuters) – U.S.-listed shares of Alibaba (NYSE:BABA) Group Holding dipped on Friday following a Morgan Stanley downgrade on concerns over…

Earnings call: Cansortium Reports record revenue and cash flow generation in Q3 2023

Cansortium (OTC:CNTMF) Inc., a leading medical cannabis company, reported significant growth in its third-quarter 2023 earnings call, with record revenue…

Earnings call: Patterson Companies adjusts fiscal 2024 guidance amid macroeconomic challenges

Patterson Companies, Inc. has reported a mixed performance in its second-quarter fiscal 2024 earnings call, with growth in some areas…

AstraZeneca halts Phase III trials for kidney disease treatment

AstraZeneca (NASDAQ:AZN) plc has announced the discontinuation of its Phase III STABILIZE-CKD and DIALIZE-Outcomes trials, which were investigating treatments for…